News

MBM Commercial, led by Alexander Lamley, Director, recently assisted In4Derm, an innovative drug discovery company and winner of the 2109 Converge Challenge, in their seed investment round.  The firm secured seed investment for their next-gen topical and oral therapies for widespread inflammatory conditions such as eczema and rheumatoid arthritis.In4Derm spun out of Dundee University in July 2020 and specialize in the discovery of drugs, which are safe and effective, for the treatment of skin diseases. The funding was led by o2h Ventures.“Alex[ander] and team have been with us from the outset,” noted Dr Andrew Woodland, Chief Scientific Officer. “From the Converge...

Joining us this week is Charlie Hodges, Managing Director at Augusta & Co., an independent London-based specialist financial advisory and investment house serving the European renewable energy sector.

In this episode, we chat with David Nix, Managing Director at Ready4Retirement. David has a view from both sides of the M&Amp;A equation, having sold his business and then bought it back.

MBM’s corporate team, led by Alexander Lamley, Director, with support from Yavor Georgiev recently advised SICCAR (previously known as Wallet Services) on its recent funding round.

We recently spoke with Celtic Renewables' CEO, Mark Simmers, to chat to him about the firm's journey from start-up in the lab to now, building out their first industrial-scale biorefinery.